img

Global Biosimilars & Follow-on-Biologics Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Biosimilars & Follow-on-Biologics Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Biosimilars & Follow-on-Biologics report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Biosimilars & Follow-on-Biologics market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Blood Disorders and Oncology Diseases are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Biosimilars & Follow-on-Biologics industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Biosimilars & Follow-on-Biologics key manufacturers include Novartis, Synthon Pharmaceuticals, Teva Pharmaceutical Industries, LG Life Sciences, Celltrion, Biocon, Hospira, Merck Group and Biogen idec, Inc., etc. Novartis, Synthon Pharmaceuticals, Teva Pharmaceutical Industries are top 3 players and held % sales share in total in 2022.
Biosimilars & Follow-on-Biologics can be divided into Human Growth Hormone, Erythropoietin, Monoclonal Antibodies and Insulin, etc. Human Growth Hormone is the mainstream product in the market, accounting for % sales share globally in 2022.
Biosimilars & Follow-on-Biologics is widely used in various fields, such as Blood Disorders, Oncology Diseases, Chronic and Autoimmune Diseases and Growth Hormone Deficiencies, etc. Blood Disorders provides greatest supports to the Biosimilars & Follow-on-Biologics industry development. In 2022, global % sales of Biosimilars & Follow-on-Biologics went into Blood Disorders filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Biosimilars & Follow-on-Biologics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Novartis
Synthon Pharmaceuticals
Teva Pharmaceutical Industries
LG Life Sciences
Celltrion
Biocon
Hospira
Merck Group
Biogen idec, Inc.
Genentech (Roche Group)
Segment by Type
Human Growth Hormone
Erythropoietin
Monoclonal Antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor
Peptide
Others

Segment by Application


Blood Disorders
Oncology Diseases
Chronic and Autoimmune Diseases
Growth Hormone Deficiencies
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Biosimilars & Follow-on-Biologics market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Biosimilars & Follow-on-Biologics, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Biosimilars & Follow-on-Biologics industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Biosimilars & Follow-on-Biologics in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Biosimilars & Follow-on-Biologics introduction, etc. Biosimilars & Follow-on-Biologics Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Biosimilars & Follow-on-Biologics market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Biosimilars & Follow-on-Biologics Market Overview
1.1 Biosimilars & Follow-on-Biologics Product Overview
1.2 Biosimilars & Follow-on-Biologics Market Segment by Type
1.2.1 Human Growth Hormone
1.2.2 Erythropoietin
1.2.3 Monoclonal Antibodies
1.2.4 Insulin
1.2.5 Interferon
1.2.6 Granulocyte-Colony Stimulating Factor
1.2.7 Peptide
1.2.8 Others
1.3 Global Biosimilars & Follow-on-Biologics Market Size by Type
1.3.1 Global Biosimilars & Follow-on-Biologics Market Size Overview by Type (2018-2034)
1.3.2 Global Biosimilars & Follow-on-Biologics Historic Market Size Review by Type (2018-2024)
1.3.3 Global Biosimilars & Follow-on-Biologics Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Biosimilars & Follow-on-Biologics Sales Breakdown by Type (2018-2024)
1.4.2 Europe Biosimilars & Follow-on-Biologics Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Biosimilars & Follow-on-Biologics Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Biosimilars & Follow-on-Biologics Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Biosimilars & Follow-on-Biologics Sales Breakdown by Type (2018-2024)
2 Global Biosimilars & Follow-on-Biologics Market Competition by Company
2.1 Global Top Players by Biosimilars & Follow-on-Biologics Sales (2018-2024)
2.2 Global Top Players by Biosimilars & Follow-on-Biologics Revenue (2018-2024)
2.3 Global Top Players by Biosimilars & Follow-on-Biologics Price (2018-2024)
2.4 Global Top Manufacturers Biosimilars & Follow-on-Biologics Manufacturing Base Distribution, Sales Area, Product Type
2.5 Biosimilars & Follow-on-Biologics Market Competitive Situation and Trends
2.5.1 Biosimilars & Follow-on-Biologics Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Biosimilars & Follow-on-Biologics Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biosimilars & Follow-on-Biologics as of 2022)
2.7 Date of Key Manufacturers Enter into Biosimilars & Follow-on-Biologics Market
2.8 Key Manufacturers Biosimilars & Follow-on-Biologics Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Biosimilars & Follow-on-Biologics Status and Outlook by Region
3.1 Global Biosimilars & Follow-on-Biologics Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Biosimilars & Follow-on-Biologics Historic Market Size by Region
3.2.1 Global Biosimilars & Follow-on-Biologics Sales in Volume by Region (2018-2024)
3.2.2 Global Biosimilars & Follow-on-Biologics Sales in Value by Region (2018-2024)
3.2.3 Global Biosimilars & Follow-on-Biologics Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Biosimilars & Follow-on-Biologics Forecasted Market Size by Region
3.3.1 Global Biosimilars & Follow-on-Biologics Sales in Volume by Region (2024-2034)
3.3.2 Global Biosimilars & Follow-on-Biologics Sales in Value by Region (2024-2034)
3.3.3 Global Biosimilars & Follow-on-Biologics Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Biosimilars & Follow-on-Biologics by Application
4.1 Biosimilars & Follow-on-Biologics Market Segment by Application
4.1.1 Blood Disorders
4.1.2 Oncology Diseases
4.1.3 Chronic and Autoimmune Diseases
4.1.4 Growth Hormone Deficiencies
4.1.5 Others
4.2 Global Biosimilars & Follow-on-Biologics Market Size by Application
4.2.1 Global Biosimilars & Follow-on-Biologics Market Size Overview by Application (2018-2034)
4.2.2 Global Biosimilars & Follow-on-Biologics Historic Market Size Review by Application (2018-2024)
4.2.3 Global Biosimilars & Follow-on-Biologics Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Biosimilars & Follow-on-Biologics Sales Breakdown by Application (2018-2024)
4.3.2 Europe Biosimilars & Follow-on-Biologics Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Biosimilars & Follow-on-Biologics Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Biosimilars & Follow-on-Biologics Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Biosimilars & Follow-on-Biologics Sales Breakdown by Application (2018-2024)
5 North America Biosimilars & Follow-on-Biologics by Country
5.1 North America Biosimilars & Follow-on-Biologics Historic Market Size by Country
5.1.1 North America Biosimilars & Follow-on-Biologics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Biosimilars & Follow-on-Biologics Sales in Volume by Country (2018-2024)
5.1.3 North America Biosimilars & Follow-on-Biologics Sales in Value by Country (2018-2024)
5.2 North America Biosimilars & Follow-on-Biologics Forecasted Market Size by Country
5.2.1 North America Biosimilars & Follow-on-Biologics Sales in Volume by Country (2024-2034)
5.2.2 North America Biosimilars & Follow-on-Biologics Sales in Value by Country (2024-2034)
6 Europe Biosimilars & Follow-on-Biologics by Country
6.1 Europe Biosimilars & Follow-on-Biologics Historic Market Size by Country
6.1.1 Europe Biosimilars & Follow-on-Biologics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Biosimilars & Follow-on-Biologics Sales in Volume by Country (2018-2024)
6.1.3 Europe Biosimilars & Follow-on-Biologics Sales in Value by Country (2018-2024)
6.2 Europe Biosimilars & Follow-on-Biologics Forecasted Market Size by Country
6.2.1 Europe Biosimilars & Follow-on-Biologics Sales in Volume by Country (2024-2034)
6.2.2 Europe Biosimilars & Follow-on-Biologics Sales in Value by Country (2024-2034)
7 Asia-Pacific Biosimilars & Follow-on-Biologics by Region
7.1 Asia-Pacific Biosimilars & Follow-on-Biologics Historic Market Size by Region
7.1.1 Asia-Pacific Biosimilars & Follow-on-Biologics Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Biosimilars & Follow-on-Biologics Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Biosimilars & Follow-on-Biologics Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Biosimilars & Follow-on-Biologics Forecasted Market Size by Region
7.2.1 Asia-Pacific Biosimilars & Follow-on-Biologics Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Biosimilars & Follow-on-Biologics Sales in Value by Region (2024-2034)
8 Latin America Biosimilars & Follow-on-Biologics by Country
8.1 Latin America Biosimilars & Follow-on-Biologics Historic Market Size by Country
8.1.1 Latin America Biosimilars & Follow-on-Biologics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Biosimilars & Follow-on-Biologics Sales in Volume by Country (2018-2024)
8.1.3 Latin America Biosimilars & Follow-on-Biologics Sales in Value by Country (2018-2024)
8.2 Latin America Biosimilars & Follow-on-Biologics Forecasted Market Size by Country
8.2.1 Latin America Biosimilars & Follow-on-Biologics Sales in Volume by Country (2024-2034)
8.2.2 Latin America Biosimilars & Follow-on-Biologics Sales in Value by Country (2024-2034)
9 Middle East and Africa Biosimilars & Follow-on-Biologics by Country
9.1 Middle East and Africa Biosimilars & Follow-on-Biologics Historic Market Size by Country
9.1.1 Middle East and Africa Biosimilars & Follow-on-Biologics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Biosimilars & Follow-on-Biologics Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Biosimilars & Follow-on-Biologics Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Biosimilars & Follow-on-Biologics Forecasted Market Size by Country
9.2.1 Middle East and Africa Biosimilars & Follow-on-Biologics Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Biosimilars & Follow-on-Biologics Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Novartis
10.1.1 Novartis Company Information
10.1.2 Novartis Introduction and Business Overview
10.1.3 Novartis Biosimilars & Follow-on-Biologics Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Novartis Biosimilars & Follow-on-Biologics Products Offered
10.1.5 Novartis Recent Development
10.2 Synthon Pharmaceuticals
10.2.1 Synthon Pharmaceuticals Company Information
10.2.2 Synthon Pharmaceuticals Introduction and Business Overview
10.2.3 Synthon Pharmaceuticals Biosimilars & Follow-on-Biologics Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Synthon Pharmaceuticals Biosimilars & Follow-on-Biologics Products Offered
10.2.5 Synthon Pharmaceuticals Recent Development
10.3 Teva Pharmaceutical Industries
10.3.1 Teva Pharmaceutical Industries Company Information
10.3.2 Teva Pharmaceutical Industries Introduction and Business Overview
10.3.3 Teva Pharmaceutical Industries Biosimilars & Follow-on-Biologics Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Teva Pharmaceutical Industries Biosimilars & Follow-on-Biologics Products Offered
10.3.5 Teva Pharmaceutical Industries Recent Development
10.4 LG Life Sciences
10.4.1 LG Life Sciences Company Information
10.4.2 LG Life Sciences Introduction and Business Overview
10.4.3 LG Life Sciences Biosimilars & Follow-on-Biologics Sales, Revenue and Gross Margin (2018-2024)
10.4.4 LG Life Sciences Biosimilars & Follow-on-Biologics Products Offered
10.4.5 LG Life Sciences Recent Development
10.5 Celltrion
10.5.1 Celltrion Company Information
10.5.2 Celltrion Introduction and Business Overview
10.5.3 Celltrion Biosimilars & Follow-on-Biologics Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Celltrion Biosimilars & Follow-on-Biologics Products Offered
10.5.5 Celltrion Recent Development
10.6 Biocon
10.6.1 Biocon Company Information
10.6.2 Biocon Introduction and Business Overview
10.6.3 Biocon Biosimilars & Follow-on-Biologics Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Biocon Biosimilars & Follow-on-Biologics Products Offered
10.6.5 Biocon Recent Development
10.7 Hospira
10.7.1 Hospira Company Information
10.7.2 Hospira Introduction and Business Overview
10.7.3 Hospira Biosimilars & Follow-on-Biologics Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Hospira Biosimilars & Follow-on-Biologics Products Offered
10.7.5 Hospira Recent Development
10.8 Merck Group
10.8.1 Merck Group Company Information
10.8.2 Merck Group Introduction and Business Overview
10.8.3 Merck Group Biosimilars & Follow-on-Biologics Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Merck Group Biosimilars & Follow-on-Biologics Products Offered
10.8.5 Merck Group Recent Development
10.9 Biogen idec, Inc.
10.9.1 Biogen idec, Inc. Company Information
10.9.2 Biogen idec, Inc. Introduction and Business Overview
10.9.3 Biogen idec, Inc. Biosimilars & Follow-on-Biologics Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Biogen idec, Inc. Biosimilars & Follow-on-Biologics Products Offered
10.9.5 Biogen idec, Inc. Recent Development
10.10 Genentech (Roche Group)
10.10.1 Genentech (Roche Group) Company Information
10.10.2 Genentech (Roche Group) Introduction and Business Overview
10.10.3 Genentech (Roche Group) Biosimilars & Follow-on-Biologics Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Genentech (Roche Group) Biosimilars & Follow-on-Biologics Products Offered
10.10.5 Genentech (Roche Group) Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Biosimilars & Follow-on-Biologics Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Biosimilars & Follow-on-Biologics Industrial Chain Analysis
11.4 Biosimilars & Follow-on-Biologics Market Dynamics
11.4.1 Biosimilars & Follow-on-Biologics Industry Trends
11.4.2 Biosimilars & Follow-on-Biologics Market Drivers
11.4.3 Biosimilars & Follow-on-Biologics Market Challenges
11.4.4 Biosimilars & Follow-on-Biologics Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Biosimilars & Follow-on-Biologics Distributors
12.3 Biosimilars & Follow-on-Biologics Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Human Growth Hormone
Table 2. Major Company of Erythropoietin
Table 3. Major Company of Monoclonal Antibodies
Table 4. Major Company of Insulin
Table 5. Major Company of Interferon
Table 6. Major Company of Granulocyte-Colony Stimulating Factor
Table 7. Major Company of Peptide
Table 8. Major Company of Others
Table 9. Global Biosimilars & Follow-on-Biologics Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 10. Global Biosimilars & Follow-on-Biologics Sales by Type (2018-2024) & (K Pcs)
Table 11. Global Biosimilars & Follow-on-Biologics Sales Market Share in Volume by Type (2018-2024)
Table 12. Global Biosimilars & Follow-on-Biologics Sales by Type (2018-2024) & (US& Million)
Table 13. Global Biosimilars & Follow-on-Biologics Market Share in Value by Type (2018-2024)
Table 14. Global Biosimilars & Follow-on-Biologics Price by Type (2018-2024) & (USD/Pcs)
Table 15. Global Biosimilars & Follow-on-Biologics Sales by Type (2024-2034) & (K Pcs)
Table 16. Global Biosimilars & Follow-on-Biologics Sales Market Share in Volume by Type (2024-2034)
Table 17. Global Biosimilars & Follow-on-Biologics Sales by Type (2024-2034) & (US$ Million)
Table 18. Global Biosimilars & Follow-on-Biologics Sales Market Share in Value by Type (2024-2034)
Table 19. Global Biosimilars & Follow-on-Biologics Price by Type (2024-2034) & (USD/Pcs)
Table 20. North America Biosimilars & Follow-on-Biologics Sales by Type (2018-2024) & (K Pcs)
Table 21. North America Biosimilars & Follow-on-Biologics Sales by Type (2018-2024) & (US$ Million)
Table 22. Europe Biosimilars & Follow-on-Biologics Sales (K Pcs) by Type (2018-2024)
Table 23. Europe Biosimilars & Follow-on-Biologics Sales by Type (2018-2024) & (US$ Million)
Table 24. Asia-Pacific Biosimilars & Follow-on-Biologics Sales (K Pcs) by Type (2018-2024)
Table 25. Asia-Pacific Biosimilars & Follow-on-Biologics Sales by Type (2018-2024) & (US$ Million)
Table 26. Latin America Biosimilars & Follow-on-Biologics Sales (K Pcs) by Type (2018-2024)
Table 27. Latin America Biosimilars & Follow-on-Biologics Sales by Type (2018-2024) & (US$ Million)
Table 28. Middle East and Africa Biosimilars & Follow-on-Biologics Sales (K Pcs) by Type (2018-2024)
Table 29. Middle East and Africa Biosimilars & Follow-on-Biologics Sales by Type (2018-2024) & (US$ Million)
Table 30. Global Biosimilars & Follow-on-Biologics Sales by Company (2018-2024) & (K Pcs)
Table 31. Global Biosimilars & Follow-on-Biologics Sales Share by Company (2018-2024)
Table 32. Global Biosimilars & Follow-on-Biologics Revenue by Company (2018-2024) & (US$ Million)
Table 33. Global Biosimilars & Follow-on-Biologics Revenue Share by Company (2018-2024)
Table 34. Global Market Biosimilars & Follow-on-Biologics Price by Company (2018-2024) & (USD/Pcs)
Table 35. Global Biosimilars & Follow-on-Biologics Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 36. Global Biosimilars & Follow-on-Biologics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 37. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biosimilars & Follow-on-Biologics as of 2022)
Table 38. Date of Key Manufacturers Enter into Biosimilars & Follow-on-Biologics Market
Table 39. Key Manufacturers Biosimilars & Follow-on-Biologics Product Type
Table 40. Mergers & Acquisitions, Expansion Plans
Table 41. Global Biosimilars & Follow-on-Biologics Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 42. Global Biosimilars & Follow-on-Biologics Sales by Region (2018-2024) & (K Pcs)
Table 43. Global Biosimilars & Follow-on-Biologics Sales Market Share in Volume by Region (2018-2024)
Table 44. Global Biosimilars & Follow-on-Biologics Sales by Region (2018-2024) & (US$ Million)
Table 45. Global Biosimilars & Follow-on-Biologics Sales Market Share in Value by Region (2018-2024)
Table 46. Global Biosimilars & Follow-on-Biologics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 47. Global Biosimilars & Follow-on-Biologics Sales by Region (2024-2034) & (K Pcs)
Table 48. Global Biosimilars & Follow-on-Biologics Sales Market Share in Volume by Region (2024-2034)
Table 49. Global Biosimilars & Follow-on-Biologics Sales by Region (2024-2034) & (US$ Million)
Table 50. Global Biosimilars & Follow-on-Biologics Sales Market Share in Value by Region (2024-2034)
Table 51. Global Biosimilars & Follow-on-Biologics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 52. Global Biosimilars & Follow-on-Biologics Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 53. Global Biosimilars & Follow-on-Biologics Sales by Application (2018-2024) & (K Pcs)
Table 54. Global Biosimilars & Follow-on-Biologics Sales Market Share in Volume by Application (2018-2024)
Table 55. Global Biosimilars & Follow-on-Biologics Sales by Application (2018-2024) & (US$ Million)
Table 56. Global Biosimilars & Follow-on-Biologics Sales Market Share in Value by Application (2018-2024)
Table 57. Global Biosimilars & Follow-on-Biologics Price by Application (2018-2024) & (USD/Pcs)
Table 58. Global Biosimilars & Follow-on-Biologics Sales by Application (2024-2034) & (K Pcs)
Table 59. Global Biosimilars & Follow-on-Biologics Sales Market Share in Volume by Application (2024-2034)
Table 60. Global Biosimilars & Follow-on-Biologics Sales by Application (2024-2034) & (US$ Million)
Table 61. Global Biosimilars & Follow-on-Biologics Sales Market Share in Value by Application (2024-2034)
Table 62. Global Biosimilars & Follow-on-Biologics Price by Application (2024-2034) & (USD/Pcs)
Table 63. North America Biosimilars & Follow-on-Biologics Sales by Application (2018-2024) (K Pcs)
Table 64. North America Biosimilars & Follow-on-Biologics Sales by Application (2018-2024) & (US$ Million)
Table 65. Europe Biosimilars & Follow-on-Biologics Sales by Application (2018-2024) (K Pcs)
Table 66. Europe Biosimilars & Follow-on-Biologics Sales by Application (2018-2024) & (US$ Million)
Table 67. Asia-Pacific Biosimilars & Follow-on-Biologics Sales by Application (2018-2024) (K Pcs)
Table 68. Asia-Pacific Biosimilars & Follow-on-Biologics Sales by Application (2018-2024) & (US$ Million)
Table 69. Latin America Biosimilars & Follow-on-Biologics Sales by Application (2018-2024) (K Pcs)
Table 70. Latin America Biosimilars & Follow-on-Biologics Sales by Application (2018-2024) & (US$ Million)
Table 71. Middle East and Africa Biosimilars & Follow-on-Biologics Sales by Application (2018-2024) (K Pcs)
Table 72. Middle East and Africa Biosimilars & Follow-on-Biologics Sales by Application (2018-2024) & (US$ Million)
Table 73. North America Biosimilars & Follow-on-Biologics Sales by Country (2018-2024) & (K Pcs)
Table 74. North America Biosimilars & Follow-on-Biologics Sales Market Share in Volume by Country (2018-2024)
Table 75. North America Biosimilars & Follow-on-Biologics Sales by Country (2018-2024) & (US$ Million)
Table 76. North America Biosimilars & Follow-on-Biologics Sales Market Share in Value by Country (2018-2024)
Table 77. North America Biosimilars & Follow-on-Biologics Sales by Country (2024-2034) & (K Pcs)
Table 78. North America Biosimilars & Follow-on-Biologics Sales Market Share in Volume by Country (2024-2034)
Table 79. North America Biosimilars & Follow-on-Biologics Sales by Country (2024-2034) & (US$ Million)
Table 80. North America Biosimilars & Follow-on-Biologics Sales Market Share in Value by Country (2024-2034)
Table 81. Europe Biosimilars & Follow-on-Biologics Sales by Country (2018-2024) & (K Pcs)
Table 82. Europe Biosimilars & Follow-on-Biologics Sales Market Share in Volume by Country (2018-2024)
Table 83. Europe Biosimilars & Follow-on-Biologics Sales by Country (2018-2024) & (US$ Million)
Table 84. Europe Biosimilars & Follow-on-Biologics Sales Market Share in Value by Country (2018-2024)
Table 85. Europe Biosimilars & Follow-on-Biologics Sales by Country (2024-2034) & (K Pcs)
Table 86. Europe Biosimilars & Follow-on-Biologics Sales Market Share in Volume by Country (2024-2034)
Table 87. Europe Biosimilars & Follow-on-Biologics Sales by Country (2024-2034) & (US$ Million)
Table 88. Europe Biosimilars & Follow-on-Biologics Sales Market Share in Value by Country (2024-2034)
Table 89. Asia-Pacific Biosimilars & Follow-on-Biologics Sales by Region (2018-2024) & (K Pcs)
Table 90. Asia-Pacific Biosimilars & Follow-on-Biologics Sales Market Share in Volume by Region (2018-2024)
Table 91. Asia-Pacific Biosimilars & Follow-on-Biologics Sales by Region (2018-2024) & (US$ Million)
Table 92. Asia-Pacific Biosimilars & Follow-on-Biologics Sales Market Share in Value by Region (2018-2024)
Table 93. Asia-Pacific Biosimilars & Follow-on-Biologics Sales by Region (2024-2034) & (K Pcs)
Table 94. Asia-Pacific Biosimilars & Follow-on-Biologics Sales Market Share in Volume by Region (2024-2034)
Table 95. Asia-Pacific Biosimilars & Follow-on-Biologics Sales by Region (2024-2034) & (US$ Million)
Table 96. Asia-Pacific Biosimilars & Follow-on-Biologics Sales Market Share in Value by Region (2024-2034)
Table 97. Latin America Biosimilars & Follow-on-Biologics Sales by Country (2018-2024) & (K Pcs)
Table 98. Latin America Biosimilars & Follow-on-Biologics Sales Market Share in Volume by Country (2018-2024)
Table 99. Latin America Biosimilars & Follow-on-Biologics Sales by Country (2018-2024) & (US$ Million)
Table 100. Latin America Biosimilars & Follow-on-Biologics Sales Market Share in Value by Country (2018-2024)
Table 101. Latin America Biosimilars & Follow-on-Biologics Sales by Country (2024-2034) & (K Pcs)
Table 102. Latin America Biosimilars & Follow-on-Biologics Sales Market Share in Volume by Country (2024-2034)
Table 103. Latin America Biosimilars & Follow-on-Biologics Sales by Country (2024-2034) & (US$ Million)
Table 104. Latin America Biosimilars & Follow-on-Biologics Sales Market Share in Value by Country (2024-2034)
Table 105. Middle East and Africa Biosimilars & Follow-on-Biologics Sales by Country (2018-2024) & (K Pcs)
Table 106. Middle East and Africa Biosimilars & Follow-on-Biologics Sales Market Share in Volume by Country (2018-2024)
Table 107. Middle East and Africa Biosimilars & Follow-on-Biologics Sales by Country (2018-2024) & (US$ Million)
Table 108. Middle East and Africa Biosimilars & Follow-on-Biologics Sales Market Share in Value by Country (2018-2024)
Table 109. Middle East and Africa Biosimilars & Follow-on-Biologics Sales by Country (2024-2034) & (K Pcs)
Table 110. Middle East and Africa Biosimilars & Follow-on-Biologics Sales Market Share in Volume by Country (2024-2034)
Table 111. Middle East and Africa Biosimilars & Follow-on-Biologics Sales by Country (2024-2034) & (US$ Million)
Table 112. Middle East and Africa Biosimilars & Follow-on-Biologics Sales Market Share in Value by Country (2024-2034)
Table 113. Novartis Company Information
Table 114. Novartis Introduction and Business Overview
Table 115. Novartis Biosimilars & Follow-on-Biologics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 116. Novartis Biosimilars & Follow-on-Biologics Product
Table 117. Novartis Recent Development
Table 118. Synthon Pharmaceuticals Company Information
Table 119. Synthon Pharmaceuticals Introduction and Business Overview
Table 120. Synthon Pharmaceuticals Biosimilars & Follow-on-Biologics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 121. Synthon Pharmaceuticals Biosimilars & Follow-on-Biologics Product
Table 122. Synthon Pharmaceuticals Recent Development
Table 123. Teva Pharmaceutical Industries Company Information
Table 124. Teva Pharmaceutical Industries Introduction and Business Overview
Table 125. Teva Pharmaceutical Industries Biosimilars & Follow-on-Biologics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 126. Teva Pharmaceutical Industries Biosimilars & Follow-on-Biologics Product
Table 127. Teva Pharmaceutical Industries Recent Development
Table 128. LG Life Sciences Company Information
Table 129. LG Life Sciences Introduction and Business Overview
Table 130. LG Life Sciences Biosimilars & Follow-on-Biologics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 131. LG Life Sciences Biosimilars & Follow-on-Biologics Product
Table 132. LG Life Sciences Recent Development
Table 133. Celltrion Company Information
Table 134. Celltrion Introduction and Business Overview
Table 135. Celltrion Biosimilars & Follow-on-Biologics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 136. Celltrion Biosimilars & Follow-on-Biologics Product
Table 137. Celltrion Recent Development
Table 138. Biocon Company Information
Table 139. Biocon Introduction and Business Overview
Table 140. Biocon Biosimilars & Follow-on-Biologics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 141. Biocon Biosimilars & Follow-on-Biologics Product
Table 142. Biocon Recent Development
Table 143. Hospira Company Information
Table 144. Hospira Introduction and Business Overview
Table 145. Hospira Biosimilars & Follow-on-Biologics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 146. Hospira Biosimilars & Follow-on-Biologics Product
Table 147. Hospira Recent Development
Table 148. Merck Group Company Information
Table 149. Merck Group Introduction and Business Overview
Table 150. Merck Group Biosimilars & Follow-on-Biologics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 151. Merck Group Biosimilars & Follow-on-Biologics Product
Table 152. Merck Group Recent Development
Table 153. Biogen idec, Inc. Company Information
Table 154. Biogen idec, Inc. Introduction and Business Overview
Table 155. Biogen idec, Inc. Biosimilars & Follow-on-Biologics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 156. Biogen idec, Inc. Biosimilars & Follow-on-Biologics Product
Table 157. Biogen idec, Inc. Recent Development
Table 158. Genentech (Roche Group) Company Information
Table 159. Genentech (Roche Group) Introduction and Business Overview
Table 160. Genentech (Roche Group) Biosimilars & Follow-on-Biologics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 161. Genentech (Roche Group) Biosimilars & Follow-on-Biologics Product
Table 162. Genentech (Roche Group) Recent Development
Table 163. Key Raw Materials Lists
Table 164. Raw Materials Key Suppliers Lists
Table 165. Biosimilars & Follow-on-Biologics Market Trends
Table 166. Biosimilars & Follow-on-Biologics Market Drivers
Table 167. Biosimilars & Follow-on-Biologics Market Challenges
Table 168. Biosimilars & Follow-on-Biologics Market Restraints
Table 169. Biosimilars & Follow-on-Biologics Distributors List
Table 170. Biosimilars & Follow-on-Biologics Downstream Customers
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
List of Figures
Figure 1. Biosimilars & Follow-on-Biologics Product Picture
Figure 2. Global Biosimilars & Follow-on-Biologics Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Biosimilars & Follow-on-Biologics Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Biosimilars & Follow-on-Biologics Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of Human Growth Hormone
Figure 6. Global Human Growth Hormone Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of Erythropoietin
Figure 8. Global Erythropoietin Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of Monoclonal Antibodies
Figure 10. Global Monoclonal Antibodies Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Product Picture of Insulin
Figure 12. Global Insulin Sales YoY Growth (2018-2034) & (K Pcs)
Figure 13. Product Picture of Interferon
Figure 14. Global Interferon Sales YoY Growth (2018-2034) & (K Pcs)
Figure 15. Product Picture of Granulocyte-Colony Stimulating Factor
Figure 16. Global Granulocyte-Colony Stimulating Factor Sales YoY Growth (2018-2034) & (K Pcs)
Figure 17. Product Picture of Peptide
Figure 18. Global Peptide Sales YoY Growth (2018-2034) & (K Pcs)
Figure 19. Product Picture of Others
Figure 20. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 21. Global Biosimilars & Follow-on-Biologics Sales by Type (2018-2034) & (US$ Million)
Figure 22. Global Biosimilars & Follow-on-Biologics Sales Market Share by Type in 2022 & 2034
Figure 23. North America Biosimilars & Follow-on-Biologics Sales Market Share in Volume by Type in 2022
Figure 24. North America Biosimilars & Follow-on-Biologics Sales Market Share in Value by Type in 2022
Figure 25. Europe Biosimilars & Follow-on-Biologics Sales Market Share in Volume by Type in 2022
Figure 26. Europe Biosimilars & Follow-on-Biologics Sales Market Share in Value by Type in 2022
Figure 27. Asia-Pacific Biosimilars & Follow-on-Biologics Sales Market Share in Volume by Type in 2022
Figure 28. Asia-Pacific Biosimilars & Follow-on-Biologics Sales Market Share in Value by Type in 2022
Figure 29. Latin America Biosimilars & Follow-on-Biologics Sales Market Share in Volume by Type in 2022
Figure 30. Latin America Biosimilars & Follow-on-Biologics Sales Market Share in Value by Type in 2022
Figure 31. Middle East and Africa Biosimilars & Follow-on-Biologics Sales Market Share in Volume by Type in 2022
Figure 32. Middle East and Africa Biosimilars & Follow-on-Biologics Sales Market Share in Value by Type in 2022
Figure 33. The 5 and 10 Largest Manufacturers in the World: Market Share by Biosimilars & Follow-on-Biologics Sales in 2022
Figure 34. The 5 and 10 Largest Manufacturers in the World: Market Share by Biosimilars & Follow-on-Biologics Revenue in 2022
Figure 35. Biosimilars & Follow-on-Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 36. Product Picture of Blood Disorders
Figure 37. Global Blood Disorders Sales YoY Growth (2018-2034) & (K Pcs)
Figure 38. Product Picture of Oncology Diseases
Figure 39. Global Oncology Diseases Sales YoY Growth (2018-2034) & (K Pcs)
Figure 40. Product Picture of Chronic and Autoimmune Diseases
Figure 41. Global Chronic and Autoimmune Diseases Sales YoY Growth (2018-2034) & (K Pcs)
Figure 42. Product Picture of Growth Hormone Deficiencies
Figure 43. Global Growth Hormone Deficiencies Sales YoY Growth (2018-2034) & (K Pcs)
Figure 44. Product Picture of Others
Figure 45. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 46. Global Biosimilars & Follow-on-Biologics Sales by Application (2018-2034) & (US$ Million)
Figure 47. Global Biosimilars & Follow-on-Biologics Sales Market Share by Application in 2022 & 2034
Figure 48. North America Biosimilars & Follow-on-Biologics Sales Market Share in Volume by Application in 2022
Figure 49. North America Biosimilars & Follow-on-Biologics Sales Market Share in Value by Application in 2022
Figure 50. Europe Biosimilars & Follow-on-Biologics Sales Market Share in Volume by Application in 2022
Figure 51. Europe Biosimilars & Follow-on-Biologics Sales Market Share in Value by Application in 2022
Figure 52. Asia-Pacific Biosimilars & Follow-on-Biologics Sales Market Share in Volume by Application in 2022
Figure 53. Asia-Pacific Biosimilars & Follow-on-Biologics Sales Market Share in Value by Application in 2022
Figure 54. Latin America Biosimilars & Follow-on-Biologics Sales Market Share in Volume by Application in 2022
Figure 55. Latin America Biosimilars & Follow-on-Biologics Sales Market Share in Value by Application in 2022
Figure 56. Middle East and Africa Biosimilars & Follow-on-Biologics Sales Market Share in Value by Application in 2022
Figure 57. Key Raw Materials Price
Figure 58. Biosimilars & Follow-on-Biologics Manufacturing Cost Structure
Figure 59. Biosimilars & Follow-on-Biologics Industrial Chain Analysis
Figure 60. Channels of Distribution
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed